Why Should People With Cancer Pay Attention to Fertility?

Overview: As treatment for malignant tumors continues to improve, more young patients have the opportunity to survive for many years. Patients who hope to have children are increasingly concerned not only about how well their cancer responds to treatment, but also about protecting their ability to have children in the future.


Female and male reproductive functions differ. Female fertility is closely associated with ovarian function and the number of available eggs, while male fertility depends primarily on testicular function and sperm production. Understanding these differences can help patients and their doctors develop an appropriate fertility-protection plan before cancer treatment begins.



Why do patients with cancer need to understand their reproductive function?


For younger patients, quality of life after cancer treatment is important. Fertility is a concern for many patients and their families.


Fertility can be affected by the cancer itself or by its treatment. Chemotherapy, radiotherapy and hematopoietic stem cell transplantation (HSCT), in particular, may damage the reproductive system.


Understanding reproductive function before treatment and considering protective measures appropriate to the planned treatment are important ways to reduce potential effects on future fertility.


What are the characteristics of female reproductive function?


The female reproductive system includes internal and external reproductive organs. The internal organs mainly comprise the vagina, uterus, ovaries and fallopian tubes.


The ovaries produce and release eggs and secrete estrogen and progesterone. Protecting ovarian function is therefore an important part of preserving fertility in female patients with cancer.


Unlike men, women are born with a largely predetermined supply of eggs. Both egg number and egg quality gradually decline with age.


Normally, only approximately 400–500 eggs mature and are released through ovulation over a woman's lifetime. Ovarian function progressively declines with age, particularly after the age of 40, eventually leading to menopause and the end of natural reproductive capacity.


For young women who may receive treatment that affects ovarian function, assessing and protecting fertility before treatment is especially important.


What are the characteristics of male reproductive function?


The male reproductive system also includes internal and external reproductive organs.


Male fertility relies mainly on the testes, which produce testosterone and generate sperm in the seminiferous tubules.


An important difference is that men generally do not undergo a clearly defined end to reproductive function comparable to female menopause.


Some healthy men may still produce sperm in their seventies or even eighties. Age therefore affects male fertility differently from female fertility.


Nevertheless, men with cancer may have reduced sperm counts or impaired fertility even when their cancer does not involve reproductive organs. Possible contributors include the illness itself, nutritional status, hormonal changes, radiation exposure and anticancer drugs.


Male patients should therefore consider fertility protection before starting anticancer treatment.


Why should fertility preservation be considered before cancer treatment?


Some cancer treatments may affect the ability to have children later in life.


In women, chemotherapy and radiotherapy may damage ovarian function. Depending on age, diagnosis and the treatment plan, doctors may recommend options such as oocyte (egg) cryopreservation, embryo cryopreservation or ovarian-tissue cryopreservation.


For men, options may include sperm freezing, sperm retrieval, and, in selected circumstances, approaches involving spermatogonial stem cells or testicular-tissue preservation.


Not everyone needs fertility preservation. Doctors assess age, cancer type, planned treatment and personal reproductive wishes, and select a suitable approach without compromising necessary cancer treatment.


Summary


Female and male reproductive functions differ: female fertility depends mainly on ovarian function and ovarian reserve, while male fertility depends mainly on testicular function and sperm production.


For young patients, cancer treatment affects not only survival but also future quality of life. Understanding potential reproductive effects and planning protection with the medical team before treatment may preserve more options for the future.

FAQ

Q1: Why should women with cancer pay particular attention to ovarian function?
Women have a limited supply of eggs from birth. Chemotherapy and radiotherapy may further damage the ovaries, affecting future ovulation and fertility.
Q2: Does advancing age always mean that a man can no longer have children?
No. Men do not undergo a defined menopause, and some healthy older men continue to produce sperm. However, cancer and its treatment may impair fertility, so early assessment and protection remain important.
Q3: Does every patient with cancer need fertility preservation before treatment?
Not necessarily. A doctor should make an individualized assessment based on age, cancer type, treatment regimen and personal wishes.
Q4: Must fertility preservation take place before treatment?
Generally, the earlier fertility is assessed, the better. If treatment may impair reproductive function, patients should speak to their treating physician and reproductive-medicine team as soon as possible so that treatment does not begin before an appropriate preservation opportunity has been considered.

Contact Us

Tel: +86 17600353095

Hours: Monday–Friday, 10:00–17:00

Get Help & Support

WeChat official account QR code
Official WeChat
WeChat mini program QR code
WeChat Mini Program
Blood cancer patient group QR code
Hematologic Group
Solid tumor patient group QR code
Solid Tumor Group